FMC vs NERV · rev $1.22B vs P/E 2.2, $12.4M cap
FMC Corporation (FMC) versus Minerva Neurosciences Inc (NERV) — a side-by-side from cached financials, not a winner call.
FMC Corporation (FMC) is a agricultural inputs company listed on NYSE.
Minerva Neurosciences Inc (NERV) is a biotechnology company listed on US.
Latest reported FMC revenue for 2024-12-31 was $1.22B. Net income was -$16.1M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. FMC currently screens at market cap $1.50B.
Latest reported NERV revenue for 2024-12-31 was $0. Net income was $1.4M. NERV currently screens at market cap $12.4M and trailing P/E 2.2.
FMC currently screens at market cap $1.50B. NERV currently screens at market cap $12.4M and trailing P/E 2.2.
Not investment advice. Open the FMC and NERV stock pages for the full models.
Not investment advice.